Welcome Guest | Register / Login

Global Molecular Diagnostics Market Report: 2014 Edition

Table of Contents

1. Diagnostics: An Overview
1.1 In Vitro Diagnostics
1.2 Molecular Diagnostics

2. Diagnostics Market
2.1 Global In Vitro Diagnostics (IVD) Market
Market Value
Market Segmentation
Regional Breakdown
2.2 Global Molecular Diagnostics Market
Market Value
Market Segmentation
2.2.1 Human Papilloma Virus (HPV)
Global Market Value
Global Market Volume
US Market Value
2.2.2 CT/NG
Global Market Value
Global Market Volume
US Market Value
2.2.3 Global Genetic Testing Market
Global Market Value

3. Market Dynamics
3.1 Industry Trends and Developments
3.1.1 Moderately Complex Tests on the Rise
3.1.2 Decentralization and Pricing Pressures to Continue
3.1.3 Industry Consolidation on the Rise
3.1.4 Growing PointofCare Diagnostics
3.2 Growth Drivers
3.2.1 Increasing CT/NG Prevalence in the US
3.2.2 Ageing Population on the Rise
3.2.3 Rising Healthcare Expenditure
3.2.4 Improving Economic Conditions
3.2.5 US Guidelines Promoting Regular Screening
3.2.6 Rising Incidence of Diabetes
3.2.7 Opportunities for Oncology Diagnostics
3.3 Challenges
3.3.1 Reimbursement Guidelines Still Unclear
3.3.2 Regulatory Hurdles

4. Competitive Landscape
Molecular Diagnostics Market Share
CT/NG Market Share
HPV Market Share

5. Company Profiles
5.1 Roche Holding AG
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
Promoting Innovation and Research
Strengthening Biotech Capabilities
5.2 Novartis AG
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
Expansion through R&D and Aggressive Pipeline
Leaner Business Model with Focus on Innovation
5.3 Hologic Inc.
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
Seeking Expansion through Acquisitions
Enhancing Research and Development
5.4 Qiagen NV
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies
Extending Products and Tests Portfolio
Seeking Expansion through Acquisitions

6. Market Outlook
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis

List of Tables

Major M&A in Diagnostics
Cancer Care Cost by Cancer Site (2010 and 2020E)
Top 20 IVD Companies by Revenue (2012)
Growth of Molecular Companies (20022012)
Dependent & Independent Variables (20072013)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

List of Charts

IVD Market – Segments by Technology
Molecular Diagnostcs – Traditional Process
Main Purposes of Molecular Diagnostics
IVD Market Segment/Product Line
Global IVD Market (20062013E)
Global IVD Market Share by Segment (2013)
IVD Market Share by Geographical Region (2013E)
Global Molecular Diagnostics Market (20052013E)
Molecular Diagnostics Market Share by Segment (2013)
Molecular Diagnostics Market Share by Discipline (2013E)
Global HPV Market by Value (20102014E)
Global HPV Market by Volume (20102014E)
Global Pap Test Market (2013E)
Estimated Penetration of Liquid Based Cytology Tests (2012)
Global CT/NG Market by Value (20112015E)
Global CT/NG Market by Volume (20112015E)
Global Genetic Testing Market (20072013E)
Molecular Laboratories by Testing Menu
Global Average Selling Price (20102014E)
Incidence of Chlamydia and Gonorrhoea in the US (20002012)
Global Ageing Population (20072013)
Ageing Population in China (20082014)
Comparison of Aging Population (2012)
Global Healthcare Spending (20052015E)
Global GDP (20012013)
World GDP per Capita (20052013)
World Diabetic Population (20062013)
Oncology Market, the US (20142020E)
Global IVD Market Share by Company (2013E)
Global Molecular Diagnostics Market Share by Company (2013)
Global CT/NG Market Share by Company (2013)
Movements in Global CT/NG Market Share (20112014E)
Global HPV Market Share by Company (2013)
Movements in Global HPV Market Share (20102014E)
Roche’s Revenues by Business Segments (2013)
Diagnostics’ Revenues by SubSegments, Roche (2013)
Revenues and Net Income, Roche (20102013)
R&D Investments, Roche (20102013)
Novartis’ Revenue Share by Business Segments (2013)
Novartis’ Vaccines and Diagnostics’ Revenues by Geographies (2013)
Net Sales and Net Income, Novartis (20102013)
Revenue Share by Business Segments, Hologic (2013)
Revenue Share by Geographies, Hologic (2013)
Revenue and Net Income, Hologic (20102013)
Revenue Share by Customer Classes Served, Qiagen (2013)
Revenue Share by Geographies, Qiagen (2013)
Net Sales and Net Income, Qiagen (20102013)
Global Molecular Diagnostics Market Forecast (20072017F)

Why http://www.marketreportsonline.com/
Published By :Koncept Analytics
Price
Live Chat
Live Chat by Comm100